Opportunity
SAM #75N98026Q00891AZUREBIOSYSTEMS
NIH requests replacement UV transilluminator and imaging system for laboratory research
Buyer
NIH Office of Logistics and Acquisition Operations
Posted
July 28, 2026
Respond By
August 06, 2026
Identifier
75N98026Q00891AZUREBIOSYSTEMS
NAICS
339999, 334516
The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is seeking to procure a replacement ultraviolet (UV) transilluminator and imaging system for the Liver Diseases Branch (LDB). - Government Buyer: - National Institutes of Health (NIH) - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - Liver Diseases Branch (LDB) - Products/Services Requested: - Replacement ultraviolet transilluminator and imaging system - No specific part numbers or quantities provided - Purpose and Use: - Equipment will support laboratory research on liver diseases and viral infections - Enables visualization and documentation of biological samples during experiments - Notable Requirements: - Existing system is non-operational and cannot be repaired - Equipment is critical for ongoing, federally funded research - OEMs and Vendors: - No specific OEMs or vendors are mentioned in the solicitation
Description
The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), has a requirement to obtain a replacement ultraviolet transilluminator and imaging system for use by the Liver Diseases Branch (LDB). The existing imaging system is no longer operational and cannot be repaired. This equipment is required to support ongoing laboratory research activities that study liver diseases and viral infections. The equipment is used to visualize and document biological samples during routine laboratory experiments. These experiments support federally funded research that aims to better understand viral infections and identify potential treatments. Without a functioning imaging system, researchers will not be able to properly analyze experimental results, which would delay ongoing research activities. NIH serves as the requiring federal agency, NIDDK is the sponsoring organization, and the requirement supports the research mission of the LDB